Global Pneumococcal Vaccines Market Research Report 2022(Status and Outlook)
Report Overview
The Global Pneumococcal Vaccines Market Size was estimated at USD 7129.63 million in 2021 and is projected to reach USD 7702.93 million by 2028, exhibiting a CAGR of 1.11% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Pneumococcal Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pneumococcal Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pneumococcal Vaccines market in any manner.
Global Pneumococcal Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pneumococcal Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Pneumococcal Vaccines Market Size was estimated at USD 7129.63 million in 2021 and is projected to reach USD 7702.93 million by 2028, exhibiting a CAGR of 1.11% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Pneumococcal Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pneumococcal Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pneumococcal Vaccines market in any manner.
Global Pneumococcal Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Pfizer
- Sanofi
- GSK
- Merck
- Eli Lilly
- AstraZeneca
- Abera
- S K Chemicals
- Beijing Minhai Biotechnology
- Baxter
- Biken
- Celgene Corporation
- Panacea Biotec
- Serum Institute of India
- Genentech
- Genocea Biosciences
- ImmunoBiology
- Lupin
- Nuron Biotech
- Biogen
- Valneva Austria
- Sinovac
- PPSV 23
- PCV 7/13
- PCV 10
- For Infants
- For Children (2-10)
- For Person (10-64)
- For The Old (Above 65)
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Pneumococcal Vaccines Market
- Overview of the regional outlook of the Pneumococcal Vaccines Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pneumococcal Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pneumococcal Vaccines
1.2 Key Market Segments
1.2.1 Pneumococcal Vaccines Segment by Type
1.2.2 Pneumococcal Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PNEUMOCOCCAL VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pneumococcal Vaccines Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Pneumococcal Vaccines Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PNEUMOCOCCAL VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Global Pneumococcal Vaccines Sales by Manufacturers (2017-2022)
3.2 Global Pneumococcal Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.3 Pneumococcal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pneumococcal Vaccines Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Pneumococcal Vaccines Sales Sites, Area Served, Product Type
3.6 Pneumococcal Vaccines Market Competitive Situation and Trends
3.6.1 Pneumococcal Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pneumococcal Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PNEUMOCOCCAL VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Pneumococcal Vaccines Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PNEUMOCOCCAL VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PNEUMOCOCCAL VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pneumococcal Vaccines Sales Market Share by Type (2017-2022)
6.3 Global Pneumococcal Vaccines Market Size Market Share by Type (2017-2022)
6.4 Global Pneumococcal Vaccines Price by Type (2017-2022)
7 PNEUMOCOCCAL VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pneumococcal Vaccines Market Sales by Application (2017-2022)
7.3 Global Pneumococcal Vaccines Market Size (M USD) by Application (2017-2022)
7.4 Global Pneumococcal Vaccines Sales Growth Rate by Application (2017-2022)
8 PNEUMOCOCCAL VACCINES MARKET SEGMENTATION BY REGION
8.1 Global Pneumococcal Vaccines Sales by Region
8.1.1 Global Pneumococcal Vaccines Sales by Region
8.1.2 Global Pneumococcal Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Pneumococcal Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pneumococcal Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pneumococcal Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pneumococcal Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pneumococcal Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILED
9.1 Pfizer
9.1.1 Pfizer Pneumococcal Vaccines Basic Information
9.1.2 Pfizer Pneumococcal Vaccines Product Overview
9.1.3 Pfizer Pneumococcal Vaccines Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Pneumococcal Vaccines SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Sanofi
9.2.1 Sanofi Pneumococcal Vaccines Basic Information
9.2.2 Sanofi Pneumococcal Vaccines Product Overview
9.2.3 Sanofi Pneumococcal Vaccines Product Market Performance
9.2.4 Sanofi Business Overview
9.2.5 Sanofi Pneumococcal Vaccines SWOT Analysis
9.2.6 Sanofi Recent Developments
9.3 GSK
9.3.1 GSK Pneumococcal Vaccines Basic Information
9.3.2 GSK Pneumococcal Vaccines Product Overview
9.3.3 GSK Pneumococcal Vaccines Product Market Performance
9.3.4 GSK Business Overview
9.3.5 GSK Pneumococcal Vaccines SWOT Analysis
9.3.6 GSK Recent Developments
9.4 Merck
9.4.1 Merck Pneumococcal Vaccines Basic Information
9.4.2 Merck Pneumococcal Vaccines Product Overview
9.4.3 Merck Pneumococcal Vaccines Product Market Performance
9.4.4 Merck Business Overview
9.4.5 Merck Pneumococcal Vaccines SWOT Analysis
9.4.6 Merck Recent Developments
9.5 Eli Lilly
9.5.1 Eli Lilly Pneumococcal Vaccines Basic Information
9.5.2 Eli Lilly Pneumococcal Vaccines Product Overview
9.5.3 Eli Lilly Pneumococcal Vaccines Product Market Performance
9.5.4 Eli Lilly Business Overview
9.5.5 Eli Lilly Pneumococcal Vaccines SWOT Analysis
9.5.6 Eli Lilly Recent Developments
9.6 AstraZeneca
9.6.1 AstraZeneca Pneumococcal Vaccines Basic Information
9.6.2 AstraZeneca Pneumococcal Vaccines Product Overview
9.6.3 AstraZeneca Pneumococcal Vaccines Product Market Performance
9.6.4 AstraZeneca Business Overview
9.6.5 AstraZeneca Recent Developments
9.7 Abera
9.7.1 Abera Pneumococcal Vaccines Basic Information
9.7.2 Abera Pneumococcal Vaccines Product Overview
9.7.3 Abera Pneumococcal Vaccines Product Market Performance
9.7.4 Abera Business Overview
9.7.5 Abera Recent Developments
9.8 S K Chemicals
9.8.1 S K Chemicals Pneumococcal Vaccines Basic Information
9.8.2 S K Chemicals Pneumococcal Vaccines Product Overview
9.8.3 S K Chemicals Pneumococcal Vaccines Product Market Performance
9.8.4 S K Chemicals Business Overview
9.8.5 S K Chemicals Recent Developments
9.9 Beijing Minhai Biotechnology
9.9.1 Beijing Minhai Biotechnology Pneumococcal Vaccines Basic Information
9.9.2 Beijing Minhai Biotechnology Pneumococcal Vaccines Product Overview
9.9.3 Beijing Minhai Biotechnology Pneumococcal Vaccines Product Market Performance
9.9.4 Beijing Minhai Biotechnology Business Overview
9.9.5 Beijing Minhai Biotechnology Recent Developments
9.10 Baxter
9.10.1 Baxter Pneumococcal Vaccines Basic Information
9.10.2 Baxter Pneumococcal Vaccines Product Overview
9.10.3 Baxter Pneumococcal Vaccines Product Market Performance
9.10.4 Baxter Business Overview
9.10.5 Baxter Recent Developments
9.11 Biken
9.11.1 Biken Pneumococcal Vaccines Basic Information
9.11.2 Biken Pneumococcal Vaccines Product Overview
9.11.3 Biken Pneumococcal Vaccines Product Market Performance
9.11.4 Biken Business Overview
9.11.5 Biken Recent Developments
9.12 Celgene Corporation
9.12.1 Celgene Corporation Pneumococcal Vaccines Basic Information
9.12.2 Celgene Corporation Pneumococcal Vaccines Product Overview
9.12.3 Celgene Corporation Pneumococcal Vaccines Product Market Performance
9.12.4 Celgene Corporation Business Overview
9.12.5 Celgene Corporation Recent Developments
9.13 Panacea Biotec
9.13.1 Panacea Biotec Pneumococcal Vaccines Basic Information
9.13.2 Panacea Biotec Pneumococcal Vaccines Product Overview
9.13.3 Panacea Biotec Pneumococcal Vaccines Product Market Performance
9.13.4 Panacea Biotec Business Overview
9.13.5 Panacea Biotec Recent Developments
9.14 Serum Institute of India
9.14.1 Serum Institute of India Pneumococcal Vaccines Basic Information
9.14.2 Serum Institute of India Pneumococcal Vaccines Product Overview
9.14.3 Serum Institute of India Pneumococcal Vaccines Product Market Performance
9.14.4 Serum Institute of India Business Overview
9.14.5 Serum Institute of India Recent Developments
9.15 Genentech
9.15.1 Genentech Pneumococcal Vaccines Basic Information
9.15.2 Genentech Pneumococcal Vaccines Product Overview
9.15.3 Genentech Pneumococcal Vaccines Product Market Performance
9.15.4 Genentech Business Overview
9.15.5 Genentech Recent Developments
9.16 Genocea Biosciences
9.16.1 Genocea Biosciences Pneumococcal Vaccines Basic Information
9.16.2 Genocea Biosciences Pneumococcal Vaccines Product Overview
9.16.3 Genocea Biosciences Pneumococcal Vaccines Product Market Performance
9.16.4 Genocea Biosciences Business Overview
9.16.5 Genocea Biosciences Recent Developments
9.17 ImmunoBiology
9.17.1 ImmunoBiology Pneumococcal Vaccines Basic Information
9.17.2 ImmunoBiology Pneumococcal Vaccines Product Overview
9.17.3 ImmunoBiology Pneumococcal Vaccines Product Market Performance
9.17.4 ImmunoBiology Business Overview
9.17.5 ImmunoBiology Recent Developments
9.18 Lupin
9.18.1 Lupin Pneumococcal Vaccines Basic Information
9.18.2 Lupin Pneumococcal Vaccines Product Overview
9.18.3 Lupin Pneumococcal Vaccines Product Market Performance
9.18.4 Lupin Business Overview
9.18.5 Lupin Recent Developments
9.19 Nuron Biotech
9.19.1 Nuron Biotech Pneumococcal Vaccines Basic Information
9.19.2 Nuron Biotech Pneumococcal Vaccines Product Overview
9.19.3 Nuron Biotech Pneumococcal Vaccines Product Market Performance
9.19.4 Nuron Biotech Business Overview
9.19.5 Nuron Biotech Recent Developments
9.20 Biogen
9.20.1 Biogen Pneumococcal Vaccines Basic Information
9.20.2 Biogen Pneumococcal Vaccines Product Overview
9.20.3 Biogen Pneumococcal Vaccines Product Market Performance
9.20.4 Biogen Business Overview
9.20.5 Biogen Recent Developments
9.21 Valneva Austria
9.21.1 Valneva Austria Pneumococcal Vaccines Basic Information
9.21.2 Valneva Austria Pneumococcal Vaccines Product Overview
9.21.3 Valneva Austria Pneumococcal Vaccines Product Market Performance
9.21.4 Valneva Austria Business Overview
9.21.5 Valneva Austria Recent Developments
9.22 Sinovac
9.22.1 Sinovac Pneumococcal Vaccines Basic Information
9.22.2 Sinovac Pneumococcal Vaccines Product Overview
9.22.3 Sinovac Pneumococcal Vaccines Product Market Performance
9.22.4 Sinovac Business Overview
9.22.5 Sinovac Recent Developments
10 PNEUMOCOCCAL VACCINES MARKET FORECAST BY REGION
10.1 Global Pneumococcal Vaccines Market Size Forecast
10.2 Global Pneumococcal Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pneumococcal Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Pneumococcal Vaccines Market Size Forecast by Region
10.2.4 South America Pneumococcal Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pneumococcal Vaccines by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2022-2028)
11.1 Global Pneumococcal Vaccines Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Pneumococcal Vaccines by Type (2022-2028)
11.1.2 Global Pneumococcal Vaccines Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Pneumococcal Vaccines by Type (2022-2028)
11.2 Global Pneumococcal Vaccines Market Forecast by Application (2022-2028)
11.2.1 Global Pneumococcal Vaccines Sales (K Units) Forecast by Application
11.2.2 Global Pneumococcal Vaccines Market Size (M USD) Forecast by Application (2022-2028)
12 CONCLUSION AND KEY FINDINGSLIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pneumococcal Vaccines Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Pneumococcal Vaccines Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Pneumococcal Vaccines Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Pneumococcal Vaccines Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Pneumococcal Vaccines Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Vaccines as of 2021)
Table 10. Global Market Pneumococcal Vaccines Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Pneumococcal Vaccines Sales Sites and Area Served
Table 12. Manufacturers Pneumococcal Vaccines Product Type
Table 13. Global Pneumococcal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pneumococcal Vaccines
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pneumococcal Vaccines Market Challenges
Table 22. Market Restraints
Table 23. Global Pneumococcal Vaccines Sales by Type (K Units)
Table 24. Global Pneumococcal Vaccines Market Size by Type (M USD)
Table 25. Global Pneumococcal Vaccines Sales (K Units) by Type (2017-2022)
Table 26. Global Pneumococcal Vaccines Sales Market Share by Type (2017-2022)
Table 27. Global Pneumococcal Vaccines Market Size (M USD) by Type (2017-2022)
Table 28. Global Pneumococcal Vaccines Market Size Share by Type (2017-2022)
Table 29. Global Pneumococcal Vaccines Price (USD/Unit) by Type (2017-2022)
Table 30. Global Pneumococcal Vaccines Sales (K Units) by Application
Table 31. Global Pneumococcal Vaccines Market Size by Application
Table 32. Global Pneumococcal Vaccines Sales by Application (2017-2022) & (K Units)
Table 33. Global Pneumococcal Vaccines Sales Market Share by Application (2017-2022)
Table 34. Global Pneumococcal Vaccines Sales by Application (2017-2022) & (M USD)
Table 35. Global Pneumococcal Vaccines Market Share by Application (2017-2022)
Table 36. Global Pneumococcal Vaccines Sales Growth Rate by Application (2017-2022)
Table 37. Global Pneumococcal Vaccines Sales by Region (2017-2022) & (K Units)
Table 38. Global Pneumococcal Vaccines Sales Market Share by Region (2017-2022)
Table 39. North America Pneumococcal Vaccines Sales by Country (2017-2022) & (K Units)
Table 40. Europe Pneumococcal Vaccines Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Pneumococcal Vaccines Sales by Region (2017-2022) & (K Units)
Table 42. South America Pneumococcal Vaccines Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Pneumococcal Vaccines Sales by Region (2017-2022) & (K Units)
Table 44. Pfizer Pneumococcal Vaccines Basic Information
Table 45. Pfizer Pneumococcal Vaccines Product Overview
Table 46. Pfizer Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. Pfizer Business Overview
Table 48. Pfizer Pneumococcal Vaccines SWOT Analysis
Table 49. Pfizer Recent Developments
Table 50. Sanofi Pneumococcal Vaccines Basic Information
Table 51. Sanofi Pneumococcal Vaccines Product Overview
Table 52. Sanofi Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. Sanofi Business Overview
Table 54. Sanofi Pneumococcal Vaccines SWOT Analysis
Table 55. Sanofi Recent Developments
Table 56. GSK Pneumococcal Vaccines Basic Information
Table 57. GSK Pneumococcal Vaccines Product Overview
Table 58. GSK Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. GSK Business Overview
Table 60. GSK Pneumococcal Vaccines SWOT Analysis
Table 61. GSK Recent Developments
Table 62. Merck Pneumococcal Vaccines Basic Information
Table 63. Merck Pneumococcal Vaccines Product Overview
Table 64. Merck Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Merck Business Overview
Table 66. Merck Pneumococcal Vaccines SWOT Analysis
Table 67. Merck Recent Developments
Table 68. Eli Lilly Pneumococcal Vaccines Basic Information
Table 69. Eli Lilly Pneumococcal Vaccines Product Overview
Table 70. Eli Lilly Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Eli Lilly Business Overview
Table 72. Eli Lilly Pneumococcal Vaccines SWOT Analysis
Table 73. Eli Lilly Recent Developments
Table 74. AstraZeneca Pneumococcal Vaccines Basic Information
Table 75. AstraZeneca Pneumococcal Vaccines Product Overview
Table 76. AstraZeneca Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Recent Developments
Table 79. Abera Pneumococcal Vaccines Basic Information
Table 80. Abera Pneumococcal Vaccines Product Overview
Table 81. Abera Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Abera Business Overview
Table 83. Abera Recent Developments
Table 84. S K Chemicals Pneumococcal Vaccines Basic Information
Table 85. S K Chemicals Pneumococcal Vaccines Product Overview
Table 86. S K Chemicals Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. S K Chemicals Business Overview
Table 88. S K Chemicals Recent Developments
Table 89. Beijing Minhai Biotechnology Pneumococcal Vaccines Basic Information
Table 90. Beijing Minhai Biotechnology Pneumococcal Vaccines Product Overview
Table 91. Beijing Minhai Biotechnology Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Beijing Minhai Biotechnology Business Overview
Table 93. Beijing Minhai Biotechnology Recent Developments
Table 94. Baxter Pneumococcal Vaccines Basic Information
Table 95. Baxter Pneumococcal Vaccines Product Overview
Table 96. Baxter Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Baxter Business Overview
Table 98. Baxter Recent Developments
Table 99. Biken Pneumococcal Vaccines Basic Information
Table 100. Biken Pneumococcal Vaccines Product Overview
Table 101. Biken Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Biken Business Overview
Table 103. Biken Recent Developments
Table 104. Celgene Corporation Pneumococcal Vaccines Basic Information
Table 105. Celgene Corporation Pneumococcal Vaccines Product Overview
Table 106. Celgene Corporation Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Celgene Corporation Business Overview
Table 108. Celgene Corporation Recent Developments
Table 109. Panacea Biotec Pneumococcal Vaccines Basic Information
Table 110. Panacea Biotec Pneumococcal Vaccines Product Overview
Table 111. Panacea Biotec Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Panacea Biotec Business Overview
Table 113. Panacea Biotec Recent Developments
Table 114. Serum Institute of India Pneumococcal Vaccines Basic Information
Table 115. Serum Institute of India Pneumococcal Vaccines Product Overview
Table 116. Serum Institute of India Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Serum Institute of India Business Overview
Table 118. Serum Institute of India Recent Developments
Table 119. Genentech Pneumococcal Vaccines Basic Information
Table 120. Genentech Pneumococcal Vaccines Product Overview
Table 121. Genentech Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Genentech Business Overview
Table 123. Genentech Recent Developments
Table 124. Genocea Biosciences Pneumococcal Vaccines Basic Information
Table 125. Genocea Biosciences Pneumococcal Vaccines Product Overview
Table 126. Genocea Biosciences Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. Genocea Biosciences Business Overview
Table 128. Genocea Biosciences Recent Developments
Table 129. ImmunoBiology Pneumococcal Vaccines Basic Information
Table 130. ImmunoBiology Pneumococcal Vaccines Product Overview
Table 131. ImmunoBiology Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 132. ImmunoBiology Business Overview
Table 133. ImmunoBiology Recent Developments
Table 134. Lupin Pneumococcal Vaccines Basic Information
Table 135. Lupin Pneumococcal Vaccines Product Overview
Table 136. Lupin Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 137. Lupin Business Overview
Table 138. Lupin Recent Developments
Table 139. Nuron Biotech Pneumococcal Vaccines Basic Information
Table 140. Nuron Biotech Pneumococcal Vaccines Product Overview
Table 141. Nuron Biotech Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 142. Nuron Biotech Business Overview
Table 143. Nuron Biotech Recent Developments
Table 144. Biogen Pneumococcal Vaccines Basic Information
Table 145. Biogen Pneumococcal Vaccines Product Overview
Table 146. Biogen Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 147. Biogen Business Overview
Table 148. Biogen Recent Developments
Table 149. Valneva Austria Pneumococcal Vaccines Basic Information
Table 150. Valneva Austria Pneumococcal Vaccines Product Overview
Table 151. Valneva Austria Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 152. Valneva Austria Business Overview
Table 153. Valneva Austria Recent Developments
Table 154. Sinovac Pneumococcal Vaccines Basic Information
Table 155. Sinovac Pneumococcal Vaccines Product Overview
Table 156. Sinovac Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 157. Sinovac Business Overview
Table 158. Sinovac Recent Developments
Table 159. Global Pneumococcal Vaccines Sales Forecast by Region (K Units)
Table 160. Global Pneumococcal Vaccines Market Size Forecast by Region (M USD)
Table 161. North America Pneumococcal Vaccines Sales Forecast by Country (2022-2028) & (K Units)
Table 162. North America Pneumococcal Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 163. Europe Pneumococcal Vaccines Sales Forecast by Country (2022-2028) & (K Units)
Table 164. Europe Pneumococcal Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 165. Asia Pacific Pneumococcal Vaccines Sales Forecast by Region (2022-2028) & (K Units)
Table 166. Asia Pacific Pneumococcal Vaccines Market Size Forecast by Region (2022-2028) & (M USD)
Table 167. South America Pneumococcal Vaccines Sales Forecast by Country (2022-2028) & (K Units)
Table 168. South America Pneumococcal Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 169. Middle East and Africa Pneumococcal Vaccines Consumption Forecast by Country (2022-2028) & (Units)
Table 170. Middle East and Africa Pneumococcal Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 171. Global Pneumococcal Vaccines Sales Forecast by Type (2022-2028) & (K Units)
Table 172. Global Pneumococcal Vaccines Market Size Forecast by Type (2022-2028) & (M USD)
Table 173. Global Pneumococcal Vaccines Price Forecast by Type (2022-2028) & (USD/Unit)
Table 174. Global Pneumococcal Vaccines Sales (K Units) Forecast by Application (2022-2028)
Table 175. Global Pneumococcal Vaccines Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pneumococcal Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pneumococcal Vaccines Market Size (M USD), 2017-2028
Figure 5. Global Pneumococcal Vaccines Market Size (M USD) (2017-2028)
Figure 6. Global Pneumococcal Vaccines Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pneumococcal Vaccines Market Size (M USD) by Country (M USD)
Figure 11. Pneumococcal Vaccines Sales Share by Manufacturers in 2020
Figure 12. Global Pneumococcal Vaccines Revenue Share by Manufacturers in 2020
Figure 13. Pneumococcal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Pneumococcal Vaccines Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pneumococcal Vaccines Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pneumococcal Vaccines Market Share by Type
Figure 18. Sales Market Share of Pneumococcal Vaccines by Type (2017-2022)
Figure 19. Sales Market Share of Pneumococcal Vaccines by Type in 2021
Figure 20. Market Size Share of Pneumococcal Vaccines by Type (2017-2022)
Figure 21. Market Size Market Share of Pneumococcal Vaccines by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pneumococcal Vaccines Market Share by Application
Figure 24. Global Pneumococcal Vaccines Sales Market Share by Application (2017-2022)
Figure 25. Global Pneumococcal Vaccines Sales Market Share by Application in 2021
Figure 26. Global Pneumococcal Vaccines Market Share by Application (2017-2022)
Figure 27. Global Pneumococcal Vaccines Market Share by Application in 2020
Figure 28. Global Pneumococcal Vaccines Sales Growth Rate by Application (2017-2022)
Figure 29. Global Pneumococcal Vaccines Sales Market Share by Region (2017-2022)
Figure 30. North America Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Pneumococcal Vaccines Sales Market Share by Country in 2020
Figure 32. U.S. Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Pneumococcal Vaccines Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Pneumococcal Vaccines Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Pneumococcal Vaccines Sales Market Share by Country in 2020
Figure 37. Germany Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Pneumococcal Vaccines Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Pneumococcal Vaccines Sales Market Share by Region in 2020
Figure 44. China Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Pneumococcal Vaccines Sales and Growth Rate (K Units)
Figure 50. South America Pneumococcal Vaccines Sales Market Share by Country in 2020
Figure 51. Brazil Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Pneumococcal Vaccines Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Pneumococcal Vaccines Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Pneumococcal Vaccines Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Pneumococcal Vaccines Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Pneumococcal Vaccines Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Pneumococcal Vaccines Market Share Forecast by Type (2022-2028)
Figure 65. Global Pneumococcal Vaccines Sales Forecast by Application (2022-2028)
Figure 66. Global Pneumococcal Vaccines Market Share Forecast by Application (2022-2028)
1.1 Market Definition and Statistical Scope of Pneumococcal Vaccines
1.2 Key Market Segments
1.2.1 Pneumococcal Vaccines Segment by Type
1.2.2 Pneumococcal Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PNEUMOCOCCAL VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pneumococcal Vaccines Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Pneumococcal Vaccines Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PNEUMOCOCCAL VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Global Pneumococcal Vaccines Sales by Manufacturers (2017-2022)
3.2 Global Pneumococcal Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.3 Pneumococcal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pneumococcal Vaccines Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Pneumococcal Vaccines Sales Sites, Area Served, Product Type
3.6 Pneumococcal Vaccines Market Competitive Situation and Trends
3.6.1 Pneumococcal Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pneumococcal Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PNEUMOCOCCAL VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Pneumococcal Vaccines Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PNEUMOCOCCAL VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PNEUMOCOCCAL VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pneumococcal Vaccines Sales Market Share by Type (2017-2022)
6.3 Global Pneumococcal Vaccines Market Size Market Share by Type (2017-2022)
6.4 Global Pneumococcal Vaccines Price by Type (2017-2022)
7 PNEUMOCOCCAL VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pneumococcal Vaccines Market Sales by Application (2017-2022)
7.3 Global Pneumococcal Vaccines Market Size (M USD) by Application (2017-2022)
7.4 Global Pneumococcal Vaccines Sales Growth Rate by Application (2017-2022)
8 PNEUMOCOCCAL VACCINES MARKET SEGMENTATION BY REGION
8.1 Global Pneumococcal Vaccines Sales by Region
8.1.1 Global Pneumococcal Vaccines Sales by Region
8.1.2 Global Pneumococcal Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Pneumococcal Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pneumococcal Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pneumococcal Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pneumococcal Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pneumococcal Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILED
9.1 Pfizer
9.1.1 Pfizer Pneumococcal Vaccines Basic Information
9.1.2 Pfizer Pneumococcal Vaccines Product Overview
9.1.3 Pfizer Pneumococcal Vaccines Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Pneumococcal Vaccines SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Sanofi
9.2.1 Sanofi Pneumococcal Vaccines Basic Information
9.2.2 Sanofi Pneumococcal Vaccines Product Overview
9.2.3 Sanofi Pneumococcal Vaccines Product Market Performance
9.2.4 Sanofi Business Overview
9.2.5 Sanofi Pneumococcal Vaccines SWOT Analysis
9.2.6 Sanofi Recent Developments
9.3 GSK
9.3.1 GSK Pneumococcal Vaccines Basic Information
9.3.2 GSK Pneumococcal Vaccines Product Overview
9.3.3 GSK Pneumococcal Vaccines Product Market Performance
9.3.4 GSK Business Overview
9.3.5 GSK Pneumococcal Vaccines SWOT Analysis
9.3.6 GSK Recent Developments
9.4 Merck
9.4.1 Merck Pneumococcal Vaccines Basic Information
9.4.2 Merck Pneumococcal Vaccines Product Overview
9.4.3 Merck Pneumococcal Vaccines Product Market Performance
9.4.4 Merck Business Overview
9.4.5 Merck Pneumococcal Vaccines SWOT Analysis
9.4.6 Merck Recent Developments
9.5 Eli Lilly
9.5.1 Eli Lilly Pneumococcal Vaccines Basic Information
9.5.2 Eli Lilly Pneumococcal Vaccines Product Overview
9.5.3 Eli Lilly Pneumococcal Vaccines Product Market Performance
9.5.4 Eli Lilly Business Overview
9.5.5 Eli Lilly Pneumococcal Vaccines SWOT Analysis
9.5.6 Eli Lilly Recent Developments
9.6 AstraZeneca
9.6.1 AstraZeneca Pneumococcal Vaccines Basic Information
9.6.2 AstraZeneca Pneumococcal Vaccines Product Overview
9.6.3 AstraZeneca Pneumococcal Vaccines Product Market Performance
9.6.4 AstraZeneca Business Overview
9.6.5 AstraZeneca Recent Developments
9.7 Abera
9.7.1 Abera Pneumococcal Vaccines Basic Information
9.7.2 Abera Pneumococcal Vaccines Product Overview
9.7.3 Abera Pneumococcal Vaccines Product Market Performance
9.7.4 Abera Business Overview
9.7.5 Abera Recent Developments
9.8 S K Chemicals
9.8.1 S K Chemicals Pneumococcal Vaccines Basic Information
9.8.2 S K Chemicals Pneumococcal Vaccines Product Overview
9.8.3 S K Chemicals Pneumococcal Vaccines Product Market Performance
9.8.4 S K Chemicals Business Overview
9.8.5 S K Chemicals Recent Developments
9.9 Beijing Minhai Biotechnology
9.9.1 Beijing Minhai Biotechnology Pneumococcal Vaccines Basic Information
9.9.2 Beijing Minhai Biotechnology Pneumococcal Vaccines Product Overview
9.9.3 Beijing Minhai Biotechnology Pneumococcal Vaccines Product Market Performance
9.9.4 Beijing Minhai Biotechnology Business Overview
9.9.5 Beijing Minhai Biotechnology Recent Developments
9.10 Baxter
9.10.1 Baxter Pneumococcal Vaccines Basic Information
9.10.2 Baxter Pneumococcal Vaccines Product Overview
9.10.3 Baxter Pneumococcal Vaccines Product Market Performance
9.10.4 Baxter Business Overview
9.10.5 Baxter Recent Developments
9.11 Biken
9.11.1 Biken Pneumococcal Vaccines Basic Information
9.11.2 Biken Pneumococcal Vaccines Product Overview
9.11.3 Biken Pneumococcal Vaccines Product Market Performance
9.11.4 Biken Business Overview
9.11.5 Biken Recent Developments
9.12 Celgene Corporation
9.12.1 Celgene Corporation Pneumococcal Vaccines Basic Information
9.12.2 Celgene Corporation Pneumococcal Vaccines Product Overview
9.12.3 Celgene Corporation Pneumococcal Vaccines Product Market Performance
9.12.4 Celgene Corporation Business Overview
9.12.5 Celgene Corporation Recent Developments
9.13 Panacea Biotec
9.13.1 Panacea Biotec Pneumococcal Vaccines Basic Information
9.13.2 Panacea Biotec Pneumococcal Vaccines Product Overview
9.13.3 Panacea Biotec Pneumococcal Vaccines Product Market Performance
9.13.4 Panacea Biotec Business Overview
9.13.5 Panacea Biotec Recent Developments
9.14 Serum Institute of India
9.14.1 Serum Institute of India Pneumococcal Vaccines Basic Information
9.14.2 Serum Institute of India Pneumococcal Vaccines Product Overview
9.14.3 Serum Institute of India Pneumococcal Vaccines Product Market Performance
9.14.4 Serum Institute of India Business Overview
9.14.5 Serum Institute of India Recent Developments
9.15 Genentech
9.15.1 Genentech Pneumococcal Vaccines Basic Information
9.15.2 Genentech Pneumococcal Vaccines Product Overview
9.15.3 Genentech Pneumococcal Vaccines Product Market Performance
9.15.4 Genentech Business Overview
9.15.5 Genentech Recent Developments
9.16 Genocea Biosciences
9.16.1 Genocea Biosciences Pneumococcal Vaccines Basic Information
9.16.2 Genocea Biosciences Pneumococcal Vaccines Product Overview
9.16.3 Genocea Biosciences Pneumococcal Vaccines Product Market Performance
9.16.4 Genocea Biosciences Business Overview
9.16.5 Genocea Biosciences Recent Developments
9.17 ImmunoBiology
9.17.1 ImmunoBiology Pneumococcal Vaccines Basic Information
9.17.2 ImmunoBiology Pneumococcal Vaccines Product Overview
9.17.3 ImmunoBiology Pneumococcal Vaccines Product Market Performance
9.17.4 ImmunoBiology Business Overview
9.17.5 ImmunoBiology Recent Developments
9.18 Lupin
9.18.1 Lupin Pneumococcal Vaccines Basic Information
9.18.2 Lupin Pneumococcal Vaccines Product Overview
9.18.3 Lupin Pneumococcal Vaccines Product Market Performance
9.18.4 Lupin Business Overview
9.18.5 Lupin Recent Developments
9.19 Nuron Biotech
9.19.1 Nuron Biotech Pneumococcal Vaccines Basic Information
9.19.2 Nuron Biotech Pneumococcal Vaccines Product Overview
9.19.3 Nuron Biotech Pneumococcal Vaccines Product Market Performance
9.19.4 Nuron Biotech Business Overview
9.19.5 Nuron Biotech Recent Developments
9.20 Biogen
9.20.1 Biogen Pneumococcal Vaccines Basic Information
9.20.2 Biogen Pneumococcal Vaccines Product Overview
9.20.3 Biogen Pneumococcal Vaccines Product Market Performance
9.20.4 Biogen Business Overview
9.20.5 Biogen Recent Developments
9.21 Valneva Austria
9.21.1 Valneva Austria Pneumococcal Vaccines Basic Information
9.21.2 Valneva Austria Pneumococcal Vaccines Product Overview
9.21.3 Valneva Austria Pneumococcal Vaccines Product Market Performance
9.21.4 Valneva Austria Business Overview
9.21.5 Valneva Austria Recent Developments
9.22 Sinovac
9.22.1 Sinovac Pneumococcal Vaccines Basic Information
9.22.2 Sinovac Pneumococcal Vaccines Product Overview
9.22.3 Sinovac Pneumococcal Vaccines Product Market Performance
9.22.4 Sinovac Business Overview
9.22.5 Sinovac Recent Developments
10 PNEUMOCOCCAL VACCINES MARKET FORECAST BY REGION
10.1 Global Pneumococcal Vaccines Market Size Forecast
10.2 Global Pneumococcal Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pneumococcal Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Pneumococcal Vaccines Market Size Forecast by Region
10.2.4 South America Pneumococcal Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pneumococcal Vaccines by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2022-2028)
11.1 Global Pneumococcal Vaccines Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Pneumococcal Vaccines by Type (2022-2028)
11.1.2 Global Pneumococcal Vaccines Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Pneumococcal Vaccines by Type (2022-2028)
11.2 Global Pneumococcal Vaccines Market Forecast by Application (2022-2028)
11.2.1 Global Pneumococcal Vaccines Sales (K Units) Forecast by Application
11.2.2 Global Pneumococcal Vaccines Market Size (M USD) Forecast by Application (2022-2028)
12 CONCLUSION AND KEY FINDINGSLIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pneumococcal Vaccines Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Pneumococcal Vaccines Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Pneumococcal Vaccines Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Pneumococcal Vaccines Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Pneumococcal Vaccines Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Vaccines as of 2021)
Table 10. Global Market Pneumococcal Vaccines Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Pneumococcal Vaccines Sales Sites and Area Served
Table 12. Manufacturers Pneumococcal Vaccines Product Type
Table 13. Global Pneumococcal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pneumococcal Vaccines
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pneumococcal Vaccines Market Challenges
Table 22. Market Restraints
Table 23. Global Pneumococcal Vaccines Sales by Type (K Units)
Table 24. Global Pneumococcal Vaccines Market Size by Type (M USD)
Table 25. Global Pneumococcal Vaccines Sales (K Units) by Type (2017-2022)
Table 26. Global Pneumococcal Vaccines Sales Market Share by Type (2017-2022)
Table 27. Global Pneumococcal Vaccines Market Size (M USD) by Type (2017-2022)
Table 28. Global Pneumococcal Vaccines Market Size Share by Type (2017-2022)
Table 29. Global Pneumococcal Vaccines Price (USD/Unit) by Type (2017-2022)
Table 30. Global Pneumococcal Vaccines Sales (K Units) by Application
Table 31. Global Pneumococcal Vaccines Market Size by Application
Table 32. Global Pneumococcal Vaccines Sales by Application (2017-2022) & (K Units)
Table 33. Global Pneumococcal Vaccines Sales Market Share by Application (2017-2022)
Table 34. Global Pneumococcal Vaccines Sales by Application (2017-2022) & (M USD)
Table 35. Global Pneumococcal Vaccines Market Share by Application (2017-2022)
Table 36. Global Pneumococcal Vaccines Sales Growth Rate by Application (2017-2022)
Table 37. Global Pneumococcal Vaccines Sales by Region (2017-2022) & (K Units)
Table 38. Global Pneumococcal Vaccines Sales Market Share by Region (2017-2022)
Table 39. North America Pneumococcal Vaccines Sales by Country (2017-2022) & (K Units)
Table 40. Europe Pneumococcal Vaccines Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Pneumococcal Vaccines Sales by Region (2017-2022) & (K Units)
Table 42. South America Pneumococcal Vaccines Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Pneumococcal Vaccines Sales by Region (2017-2022) & (K Units)
Table 44. Pfizer Pneumococcal Vaccines Basic Information
Table 45. Pfizer Pneumococcal Vaccines Product Overview
Table 46. Pfizer Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. Pfizer Business Overview
Table 48. Pfizer Pneumococcal Vaccines SWOT Analysis
Table 49. Pfizer Recent Developments
Table 50. Sanofi Pneumococcal Vaccines Basic Information
Table 51. Sanofi Pneumococcal Vaccines Product Overview
Table 52. Sanofi Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. Sanofi Business Overview
Table 54. Sanofi Pneumococcal Vaccines SWOT Analysis
Table 55. Sanofi Recent Developments
Table 56. GSK Pneumococcal Vaccines Basic Information
Table 57. GSK Pneumococcal Vaccines Product Overview
Table 58. GSK Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. GSK Business Overview
Table 60. GSK Pneumococcal Vaccines SWOT Analysis
Table 61. GSK Recent Developments
Table 62. Merck Pneumococcal Vaccines Basic Information
Table 63. Merck Pneumococcal Vaccines Product Overview
Table 64. Merck Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Merck Business Overview
Table 66. Merck Pneumococcal Vaccines SWOT Analysis
Table 67. Merck Recent Developments
Table 68. Eli Lilly Pneumococcal Vaccines Basic Information
Table 69. Eli Lilly Pneumococcal Vaccines Product Overview
Table 70. Eli Lilly Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Eli Lilly Business Overview
Table 72. Eli Lilly Pneumococcal Vaccines SWOT Analysis
Table 73. Eli Lilly Recent Developments
Table 74. AstraZeneca Pneumococcal Vaccines Basic Information
Table 75. AstraZeneca Pneumococcal Vaccines Product Overview
Table 76. AstraZeneca Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Recent Developments
Table 79. Abera Pneumococcal Vaccines Basic Information
Table 80. Abera Pneumococcal Vaccines Product Overview
Table 81. Abera Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Abera Business Overview
Table 83. Abera Recent Developments
Table 84. S K Chemicals Pneumococcal Vaccines Basic Information
Table 85. S K Chemicals Pneumococcal Vaccines Product Overview
Table 86. S K Chemicals Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. S K Chemicals Business Overview
Table 88. S K Chemicals Recent Developments
Table 89. Beijing Minhai Biotechnology Pneumococcal Vaccines Basic Information
Table 90. Beijing Minhai Biotechnology Pneumococcal Vaccines Product Overview
Table 91. Beijing Minhai Biotechnology Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Beijing Minhai Biotechnology Business Overview
Table 93. Beijing Minhai Biotechnology Recent Developments
Table 94. Baxter Pneumococcal Vaccines Basic Information
Table 95. Baxter Pneumococcal Vaccines Product Overview
Table 96. Baxter Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Baxter Business Overview
Table 98. Baxter Recent Developments
Table 99. Biken Pneumococcal Vaccines Basic Information
Table 100. Biken Pneumococcal Vaccines Product Overview
Table 101. Biken Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Biken Business Overview
Table 103. Biken Recent Developments
Table 104. Celgene Corporation Pneumococcal Vaccines Basic Information
Table 105. Celgene Corporation Pneumococcal Vaccines Product Overview
Table 106. Celgene Corporation Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Celgene Corporation Business Overview
Table 108. Celgene Corporation Recent Developments
Table 109. Panacea Biotec Pneumococcal Vaccines Basic Information
Table 110. Panacea Biotec Pneumococcal Vaccines Product Overview
Table 111. Panacea Biotec Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Panacea Biotec Business Overview
Table 113. Panacea Biotec Recent Developments
Table 114. Serum Institute of India Pneumococcal Vaccines Basic Information
Table 115. Serum Institute of India Pneumococcal Vaccines Product Overview
Table 116. Serum Institute of India Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Serum Institute of India Business Overview
Table 118. Serum Institute of India Recent Developments
Table 119. Genentech Pneumococcal Vaccines Basic Information
Table 120. Genentech Pneumococcal Vaccines Product Overview
Table 121. Genentech Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Genentech Business Overview
Table 123. Genentech Recent Developments
Table 124. Genocea Biosciences Pneumococcal Vaccines Basic Information
Table 125. Genocea Biosciences Pneumococcal Vaccines Product Overview
Table 126. Genocea Biosciences Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. Genocea Biosciences Business Overview
Table 128. Genocea Biosciences Recent Developments
Table 129. ImmunoBiology Pneumococcal Vaccines Basic Information
Table 130. ImmunoBiology Pneumococcal Vaccines Product Overview
Table 131. ImmunoBiology Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 132. ImmunoBiology Business Overview
Table 133. ImmunoBiology Recent Developments
Table 134. Lupin Pneumococcal Vaccines Basic Information
Table 135. Lupin Pneumococcal Vaccines Product Overview
Table 136. Lupin Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 137. Lupin Business Overview
Table 138. Lupin Recent Developments
Table 139. Nuron Biotech Pneumococcal Vaccines Basic Information
Table 140. Nuron Biotech Pneumococcal Vaccines Product Overview
Table 141. Nuron Biotech Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 142. Nuron Biotech Business Overview
Table 143. Nuron Biotech Recent Developments
Table 144. Biogen Pneumococcal Vaccines Basic Information
Table 145. Biogen Pneumococcal Vaccines Product Overview
Table 146. Biogen Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 147. Biogen Business Overview
Table 148. Biogen Recent Developments
Table 149. Valneva Austria Pneumococcal Vaccines Basic Information
Table 150. Valneva Austria Pneumococcal Vaccines Product Overview
Table 151. Valneva Austria Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 152. Valneva Austria Business Overview
Table 153. Valneva Austria Recent Developments
Table 154. Sinovac Pneumococcal Vaccines Basic Information
Table 155. Sinovac Pneumococcal Vaccines Product Overview
Table 156. Sinovac Pneumococcal Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 157. Sinovac Business Overview
Table 158. Sinovac Recent Developments
Table 159. Global Pneumococcal Vaccines Sales Forecast by Region (K Units)
Table 160. Global Pneumococcal Vaccines Market Size Forecast by Region (M USD)
Table 161. North America Pneumococcal Vaccines Sales Forecast by Country (2022-2028) & (K Units)
Table 162. North America Pneumococcal Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 163. Europe Pneumococcal Vaccines Sales Forecast by Country (2022-2028) & (K Units)
Table 164. Europe Pneumococcal Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 165. Asia Pacific Pneumococcal Vaccines Sales Forecast by Region (2022-2028) & (K Units)
Table 166. Asia Pacific Pneumococcal Vaccines Market Size Forecast by Region (2022-2028) & (M USD)
Table 167. South America Pneumococcal Vaccines Sales Forecast by Country (2022-2028) & (K Units)
Table 168. South America Pneumococcal Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 169. Middle East and Africa Pneumococcal Vaccines Consumption Forecast by Country (2022-2028) & (Units)
Table 170. Middle East and Africa Pneumococcal Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 171. Global Pneumococcal Vaccines Sales Forecast by Type (2022-2028) & (K Units)
Table 172. Global Pneumococcal Vaccines Market Size Forecast by Type (2022-2028) & (M USD)
Table 173. Global Pneumococcal Vaccines Price Forecast by Type (2022-2028) & (USD/Unit)
Table 174. Global Pneumococcal Vaccines Sales (K Units) Forecast by Application (2022-2028)
Table 175. Global Pneumococcal Vaccines Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pneumococcal Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pneumococcal Vaccines Market Size (M USD), 2017-2028
Figure 5. Global Pneumococcal Vaccines Market Size (M USD) (2017-2028)
Figure 6. Global Pneumococcal Vaccines Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pneumococcal Vaccines Market Size (M USD) by Country (M USD)
Figure 11. Pneumococcal Vaccines Sales Share by Manufacturers in 2020
Figure 12. Global Pneumococcal Vaccines Revenue Share by Manufacturers in 2020
Figure 13. Pneumococcal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Pneumococcal Vaccines Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pneumococcal Vaccines Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pneumococcal Vaccines Market Share by Type
Figure 18. Sales Market Share of Pneumococcal Vaccines by Type (2017-2022)
Figure 19. Sales Market Share of Pneumococcal Vaccines by Type in 2021
Figure 20. Market Size Share of Pneumococcal Vaccines by Type (2017-2022)
Figure 21. Market Size Market Share of Pneumococcal Vaccines by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pneumococcal Vaccines Market Share by Application
Figure 24. Global Pneumococcal Vaccines Sales Market Share by Application (2017-2022)
Figure 25. Global Pneumococcal Vaccines Sales Market Share by Application in 2021
Figure 26. Global Pneumococcal Vaccines Market Share by Application (2017-2022)
Figure 27. Global Pneumococcal Vaccines Market Share by Application in 2020
Figure 28. Global Pneumococcal Vaccines Sales Growth Rate by Application (2017-2022)
Figure 29. Global Pneumococcal Vaccines Sales Market Share by Region (2017-2022)
Figure 30. North America Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Pneumococcal Vaccines Sales Market Share by Country in 2020
Figure 32. U.S. Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Pneumococcal Vaccines Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Pneumococcal Vaccines Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Pneumococcal Vaccines Sales Market Share by Country in 2020
Figure 37. Germany Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Pneumococcal Vaccines Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Pneumococcal Vaccines Sales Market Share by Region in 2020
Figure 44. China Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Pneumococcal Vaccines Sales and Growth Rate (K Units)
Figure 50. South America Pneumococcal Vaccines Sales Market Share by Country in 2020
Figure 51. Brazil Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Pneumococcal Vaccines Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Pneumococcal Vaccines Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Pneumococcal Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Pneumococcal Vaccines Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Pneumococcal Vaccines Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Pneumococcal Vaccines Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Pneumococcal Vaccines Market Share Forecast by Type (2022-2028)
Figure 65. Global Pneumococcal Vaccines Sales Forecast by Application (2022-2028)
Figure 66. Global Pneumococcal Vaccines Market Share Forecast by Application (2022-2028)
